Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Viability assessment with MRI is superior to FDG-PET for viability: Pro.

× No keyword cloud information.

34 in total

1. The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure.

Authors: Christoph Klein; Stephan G Nekolla; Thomas Balbach; Bernhard Schnackenburg; Eike Nagel; Eckart Fleck; Markus Schwaiger
Journal: J Magn Reson Imaging Date: 2004-10 Impact factor: 4.813

2. The hibernating myocardium.

Authors: S H Rahimtoola
Journal: Am Heart J Date: 1989-01 Impact factor: 4.749

3. Predictive value of planar 18F-fluorodeoxyglucose imaging for cardiac events in patients after acute myocardial infarction.

Authors: J M Huitink; F C Visser; J J Bax; A van Lingen; A B Groenveld; G J Teule; C A Visser
Journal: Am J Cardiol Date: 1998-05-01 Impact factor: 2.778

4. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.

Authors: J vom Dahl; C Altehoefer; F H Sheehan; P Buechin; G Schulz; E R Schwarz; K C Koch; R Uebis; B J Messmer; U Buell; P Hanrath
Journal: J Nucl Med Date: 1997-05 Impact factor: 10.057

5. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.

Authors: H J Weinmann; M Laniado; W Mützel
Journal: Physiol Chem Phys Med NMR Date: 1984

6. Mechanism of late gadolinium enhancement in patients with acute myocardial infarction.

Authors: Christoph Klein; Thaiz R Schmal; Stephan G Nekolla; Bernhard Schnackenburg; Eckart Fleck; Eike Nagel
Journal: J Cardiovasc Magn Reson Date: 2007 Impact factor: 5.364

Review 7. Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis.

Authors: Mark A Perazella
Journal: Curr Drug Saf Date: 2008-01

8. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors: J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal: N Engl J Med Date: 1986-04-03 Impact factor: 91.245

9. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography.

Authors: D Eitzman; Z al-Aouar; H L Kanter; J vom Dahl; M Kirsh; G M Deeb; M Schwaiger
Journal: J Am Coll Cardiol Date: 1992-09 Impact factor: 24.094

10. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.

Authors: T Ohtake; I Yokoyama; T Watanabe; T Momose; T Serezawa; J Nishikawa; Y Sasaki
Journal: J Nucl Med Date: 1995-03 Impact factor: 10.057

3 in total

1. The case for cardiac magnetic resonance and positron emission tomography multimodality imaging of myocardial viability.

Authors: George A Beller
Journal: J Nucl Cardiol Date: 2010-08 Impact factor: 5.952

Review 2. Advances in nuclear cardiac instrumentation with a view towards reduced radiation exposure.

Authors: Piotr J Slomka; Damini Dey; W Lane Duvall; Milena J Henzlova; Daniel S Berman; Guido Germano
Journal: Curr Cardiol Rep Date: 2012-04 Impact factor: 2.931

Review 3. Noninvasive assessment myocardial viability: current status and future directions.

Authors: Kevin C Allman
Journal: J Nucl Cardiol Date: 2013-06-15 Impact factor: 5.952

3 in total